002107.SZ SHZ
Shandong Wohua Pharmaceutical Co., Ltd.
1W: -3.3%
1M: +5.8%
3M: +11.8%
YTD: -3.0%
1Y: +2.0%
3Y: +27.8%
5Y: +2.3%
¥7.09 ($1.06)
-0.01 (-0.14%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$129M
+40.5% ▲
5Y CAGR: -8.1%
Capital Expenditures
$865K
+77.4% ▲
5Y CAGR: -56.3%
Free Cash Flow
$128M
+45.6% ▲
5Y CAGR: -2.2%
Dividends Paid
$69M
+52.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$50M
+187.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $163M | $107M | $47M | $34M | $96M |
| Depreciation & Amort. | $33M | $35M | $33M | $32M | $31M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$14M | $55M | $45M | $23M | $11M |
| Other Non-Cash Items | $16M | -$15M | $4M | $2M | -$9M |
| Operating Cash Flow | $200M | $185M | $129M | $92M | $129M |
| — Investing Activities — | |||||
| Capital Expenditures | -$19M | -$7M | -$3M | -$4M | -$865K |
| Acquisitions (Net) | $0 | $1M | $0 | $0 | $15M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $93K | $224K | $0 |
| Investing Cash Flow | -$19M | -$6M | -$3M | -$4M | $15M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$189M | $35K | -$614K | -$348K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$155M | -$150M | $0 | -$144M | -$69M |
| Other Financing | $0 | -$79M | -$3M | $0 | -$23M |
| Financing Cash Flow | -$344M | -$229M | -$4M | -$145M | -$92M |
| Net Change in Cash | -$163M | -$50M | $123M | -$57M | $50M |
| Cash End of Period | $326M | $277M | $400M | $343M | $394M |
| Free Cash Flow | $181M | $178M | $127M | $88M | $128M |